(IR) Ingersoll Rand - Ratings and Ratios
Compressor, Pump, Blower, Vacuum, Tool
IR EPS (Earnings per Share)
IR Revenue
Description: IR Ingersoll Rand October 14, 2025
Ingersoll Rand Inc. (NYSE: IR) is a diversified industrial-technology firm that delivers mission-critical air, fluid, energy, and medical solutions worldwide through two primary segments: Industrial Technologies & Services and Precision & Science Technologies.
The Industrial Technologies & Services segment manufactures and services air- and gas-compression, vacuum, blower, fluid-transfer, power-tool, and lifting-equipment product lines, along with aftermarket parts and services, under brands such as Ingersoll Rand, Gardner Denver, Nash, CompAir, and Elmo Rietschle.
The Precision & Science Technologies segment focuses on high-precision dosing and fluid-handling equipment-including diaphragm, piston, peristaltic, and progressive-cavity pumps, hydrogen compressors, and automated liquid-handling systems-served to medical, laboratory, life-science, industrial manufacturing, water-treatment, chemical, energy, food-beverage, and agricultural markets under a broad portfolio of brands (e.g., Air Dimensions, Haskel, Milton Roy, Seepex).
Key quantitative signals (FY 2023) include total revenue of approximately $15.2 billion, an adjusted EBITDA margin of roughly 14 %, and a free-cash-flow conversion of 70 % of EBITDA, reflecting strong cash generation despite a cyclical industrial backdrop. The global compressed-air market is projected to grow at a 4 % CAGR through 2029, while demand for hydrogen-compression systems is accelerating as green-hydrogen projects expand-both trends that underpin IR’s growth outlook.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of IR’s cash-flow trends and peer-relative valuation multiples.
IR Stock Overview
| Market Cap in USD | 30,158m |
| Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception | 2017-05-12 |
IR Stock Ratings
| Growth Rating | 11.2% |
| Fundamental | 63.7% |
| Dividend Rating | 5.05% |
| Return 12m vs S&P 500 | -34.3% |
| Analyst Rating | 3.94 of 5 |
IR Dividends
| Dividend Yield 12m | 0.10% |
| Yield on Cost 5y | 0.19% |
| Annual Growth 5y | -47.59% |
| Payout Consistency | 82.4% |
| Payout Ratio | 2.5% |
IR Growth Ratios
| Growth Correlation 3m | -26.6% |
| Growth Correlation 12m | -66.8% |
| Growth Correlation 5y | 84.8% |
| CAGR 5y | 12.14% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.33 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.36 |
| Sharpe Ratio 12m | -1.37 |
| Alpha | -44.21 |
| Beta | 1.431 |
| Volatility | 26.71% |
| Current Volume | 2576.9k |
| Average Volume 20d | 3060.5k |
| Stop Loss | 74.4 (-4%) |
| Signal | 0.02 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (545.1m TTM) > 0 and > 6% of Revenue (6% = 447.5m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -0.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 30.00% (prev 33.75%; Δ -3.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.38b > Net Income 545.1m (YES >=105%, WARN >=100%) |
| Net Debt (-1.18b) to EBITDA (1.53b) ratio: -0.77 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (283.8m) change vs 12m ago -30.24% (target <= -2.0% for YES) |
| Gross Margin 43.72% (prev 43.81%; Δ -0.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.98% (prev 39.32%; Δ 1.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.16 (EBITDA TTM 1.53b / Interest Expense TTM 250.8m) >= 6 (WARN >= 3) |
Altman Z'' 1.95
| (A) 0.12 = (Total Current Assets 4.16b - Total Current Liabilities 1.93b) / Total Assets 18.19b |
| (B) 0.15 = Retained Earnings (Balance) 2.79b / Total Assets 18.19b |
| (C) 0.04 = EBIT TTM 792.0m / Avg Total Assets 18.20b |
| (D) 0.33 = Book Value of Equity 2.63b / Total Liabilities 8.00b |
| Total Rating: 1.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.73
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 4.51% = 2.26 |
| 3. FCF Margin 17.53% = 4.38 |
| 4. Debt/Equity 0.00 = 2.50 |
| 5. Debt/Ebitda -0.77 = 2.50 |
| 6. ROIC - WACC (= -7.23)% = -9.04 |
| 7. RoE 5.33% = 0.44 |
| 8. Rev. Trend 81.28% = 6.10 |
| 9. EPS Trend 61.70% = 3.09 |
What is the price of IR shares?
Over the past week, the price has changed by +1.53%, over one month by -4.73%, over three months by +1.62% and over the past year by -25.07%.
Is Ingersoll Rand a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IR is around 71.14 USD . This means that IR is currently overvalued and has a potential downside of -8.21%.
Is IR a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 90.3 | 16.5% |
| Analysts Target Price | 90.3 | 16.5% |
| ValueRay Target Price | 81.3 | 4.9% |
IR Fundamental Data Overview November 02, 2025
P/E Trailing = 56.5407
P/E Forward = 22.6244
P/S = 4.0951
P/B = 3.3168
P/EG = 1.149
Beta = 1.431
Revenue TTM = 7.46b USD
EBIT TTM = 792.0m USD
EBITDA TTM = 1.53b USD
Long Term Debt = 4.75b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.40m USD (from shortTermDebt, last quarter)
Debt = 1.40m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.18b USD (from netDebt column, last quarter)
Enterprise Value = 28.98b USD (30.16b + Debt 1.40m - CCE 1.18b)
Interest Coverage Ratio = 3.16 (Ebit TTM 792.0m / Interest Expense TTM 250.8m)
FCF Yield = 4.51% (FCF TTM 1.31b / Enterprise Value 28.98b)
FCF Margin = 17.53% (FCF TTM 1.31b / Revenue TTM 7.46b)
Net Margin = 7.31% (Net Income TTM 545.1m / Revenue TTM 7.46b)
Gross Margin = 43.72% ((Revenue TTM 7.46b - Cost of Revenue TTM 4.20b) / Revenue TTM)
Gross Margin QoQ = 43.74% (prev 43.69%)
Tobins Q-Ratio = 1.59 (Enterprise Value 28.98b / Total Assets 18.19b)
Interest Expense / Debt = 4650 % (Interest Expense 65.1m / Debt 1.40m)
Taxrate = 23.04% (73.6m / 319.4m)
NOPAT = 609.5m (EBIT 792.0m * (1 - 23.04%))
Current Ratio = 2.16 (Total Current Assets 4.16b / Total Current Liabilities 1.93b)
Debt / Equity = 0.00 (Debt 1.40m / totalStockholderEquity, last quarter 10.12b)
Debt / EBITDA = -0.77 (Net Debt -1.18b / EBITDA 1.53b)
Debt / FCF = -0.90 (Net Debt -1.18b / FCF TTM 1.31b)
Total Stockholder Equity = 10.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.00% (Net Income 545.1m / Total Assets 18.19b)
RoE = 5.33% (Net Income TTM 545.1m / Total Stockholder Equity 10.22b)
RoCE = 5.29% (EBIT 792.0m / Capital Employed (Equity 10.22b + L.T.Debt 4.75b))
RoIC = 4.06% (NOPAT 609.5m / Invested Capital 15.02b)
WACC = 11.29% (E(30.16b)/V(30.16b) * Re(11.29%) + (debt cost/tax rate unavailable))
Discount Rate = 11.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.37%
[DCF Debug] Terminal Value 71.62% ; FCFE base≈1.33b ; Y1≈1.64b ; Y5≈2.80b
Fair Price DCF = 72.10 (DCF Value 28.49b / Shares Outstanding 395.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 61.70 | EPS CAGR: 6.67% | SUE: -0.23 | # QB: 0
Revenue Correlation: 81.28 | Revenue CAGR: 6.99% | SUE: 0.22 | # QB: 0
Additional Sources for IR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle